Marly Garnreiter plugged her mysterious symptoms into ChatGPT but "ignored" the results — until doctors came to the same ...

During a live event, Nathan M. Denlinger, DO, MS, discussed the TRANSFORM trial of lisocabtagene maraleucel in B-cell ...

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering statin medications at the start of their cancer treatment had a 61% lower risk ...

Newer-generation Bruton's tyrosine kinase (BTK) inhibitors have found a place in the management of follicular lymphoma, a ...

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering ...

With the help of a trusted mentor, this Outstanding Women in Business honoree started her own business in her 20s.

OLYMPIA, Wash. – Governor Bob Ferguson signed a new law on Tuesday that will prevent medical debt from impacting credit ...

Diffuse large B-cell lymphoma (DLBCL) is the most common and fast-growing type of non-Hodgkin lymphoma, a cancer that affects ...

It’s spring, a time for new beginnings following a cancer diagnosis; however, I have an ongoing issue that I can’t dismiss.

The first patient with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell therapy MB-105.

Dave Coulier revealed on the 'How Rude, Tanneritos!' podcast that he celebrated two huge milestones on the same day.

Progress has been made in reducing overall cancer mortality, largely driven by sustained declines in lung cancer,” the researchers wrote.